Summit X, LLC Abbott Laboratories Transaction History

Summit X, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $216,184 - $261,297	-2,118 Closed	0 $0
Q1 2022 May 05, 2022	SELL	$114.02 - $139.04 $51,537 - $62,846	-452 Reduced 17.59%	2,118 $250,000
Q4 2020 Jan 29, 2021	BUY	$105.0 - $114.42 $3,255 - $3,547	31 Added 1.22%	2,570 $282,000
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $9,164 - $11,129	-100 Reduced 3.79%	2,539 $762,000
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $202,068 - $258,622	2,639 New	2,639 $241,000

Q1 2020 May 13, 2020	SELL	$62.82 - $91.86 $149,071 - $217,983	-2,373 Closed	0 $0
Q3 2019 Oct 15, 2019	BUY	$81.84 - $88.74 $194,206 - $210,580	2,373 New	2,373 $200,000

3,130

1.29B

8.43M

8.71M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $182B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Summit X, LLC, based on Form 13F filings with the SEC.

Stay updated on Summit X, LLC with notifications on news.